Clinical trials
Phase 1 Inflammatory Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| National Cancer Institute (NCI) | 2 |
| Carisma Therapeutics Inc | 1 |
| Case Comprehensive Cancer Center | 1 |
| Cylene Pharmaceuticals | 1 |
| Dana-Farber Cancer Institute | 1 |
| Joseph Baar, MD, PhD | 1 |
| Northwestern University | 1 |
| University of Illinois at Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Breast Neoplasms | 11 |
| Breast Neoplasms | 9 |
| Bile Duct Neoplasms | 4 |
| Breast Neoplasms, Male | 4 |
| Carcinoma, Hepatocellular | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Pancreatic Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma, Medullary | 3 |
| Carcinoma, Ovarian Epithelial | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.